GSK Launches Two-Dose Schedule for Cervarix® HPV Vaccine in Girls Aged 9–14 in China

On April 23, GSK announced the official launch in China of the two-dose vaccination schedule for girls aged 9-14 using its imported bivalent HPV vaccine, Cervarix®.